Supplementary Figure 1 from Sensitivity of Glioblastomas to Clinically Available MEK Inhibitors Is Defined by Neurofibromin 1 Deficiency
crossref（2023）
摘要
PDF file - 809K, Immunoblot analysis of NF1-deficient GBM cells treated with AZD6244
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要